Skip to main content
Premium Trial:

Request an Annual Quote

This Week in the Medical Journals: Jul 6, 2012

Premium

In a JAMA news brief, science writer Tracy Hampton examines how gylcine comsumption and expression of the mitochondrial glycine biosynthetic pathway relate to cancer cell proliferation rates, referencing a recent Science paper from the Broad Institute's Mohit Jain et al. "Higher expression of this pathway was linked with mortality in patients with breast cancer," Hampton reports.

"Poor record keeping at a London NHS hospital trust meant that more than 1,000 patients referred for suspected cancer were not properly recorded as having been seen or, where appropriate, treated," Nigel Hawkes reports over in BMJ this week. He adds that a review group has been set up to investigate 74 cases.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.